KSX 0.00% 1.5¢ karmelsonix ltd

welcome new ceo thomas, page-4

  1. 3,646 Posts.
    lightbulb Created with Sketch. 8
    More Info:


    Mr. Thomas has over 21 years of experience in the healthcare industry in various executive positions. Currently, he is the President & CEO of a healthcare advisory firm focused on strategy development and implementation for medical device and healthcare services firms ranging in size from early stage start up to Fortune 50 global conglomerates. Prior to that, he was President and CEO of Sleep Solutions, Inc., (SSI) a venture capital backed medical device manufacturer and national healthcare service provider. Mr. Thomas was also a member of the Board of Directors for AdvaMed, the world??s largest and most prestigious medical device association.

    Prior to SSI, he was Executive Vice President of Sales and Marketing for National Sleep Technologies Inc. (NST). He helped create the first national brand in the highly fragmented diagnostic lab testing services market. Having held various sales and marketing positions, including seven years with Merck and Glaxo Wellcome, he has earned numerous awards for sales and management achievements. Mr. Thomas graduated from Cornell University with a bachelor's degree in Microbiology.



    Mike Thomas
    Mr. Thomas has over 22 years of experience in the healthcare industry in various executive positions. He is the President & CEO of Appian Partners, a healthcare advisory firm focused on strategy development and implementation for medical device and healthcare services firms ranging in size from early stage start up to Fortune 50 global conglomerates. Prior to that, he was President and CEO of Sleep Solutions, Inc., (SSI) a venture capital backed medical device manufacturer and national healthcare service provider. He raised over $50MM in venture capital funding to develop and launch a new industry in the $5 billion Sleep Medicine market. He successfully lobbied the largest Managed Care Organizations (MCOs) and the Centers for Medicare and Medicaid Services (CMS) to alter their medical policy and approve reimbursement for in home sleep apnea diagnostic testing services. Mr. Thomas was also a member of the Board of Directors for AdvaMed, the world's largest and most prestigious medical device association. While a BOD member for AdvaMed, he participated in the successful renegotiations with the FDA for the MEDUFMA II legislation (the FDA's regulatory approval process for medical devices), with leaders on Capitol Hill regarding the Remote Monitoring legislation, and sat on the BOD sub committee for International Affairs. Prior to SSI, he was Executive Vice President of Sales and Marketing for National Sleep Technologies Inc. (NST). As an executive and Board member, he identified and closed 12 acquisitions representing over 80 sleep labs that led to NST becoming the largest U.S. sleep-testing company at that time. He helped create the first national brand in the highly fragmented sleep apnea diagnostic lab testing services market. He recruited and managed a sales and marketing team that achieved a same-store sales growth rate that was 2 times greater than the industry average for four consecutive years. He helped raise over $15MM in venture capital financing and eventually sell the company to a wholly owned subsidiary of GE Medical (NYSE: GE). Previous to SSI, Mr. Thomas was instrumental as the Vice President of Sales in building sales and marketing for Patient InfoSystems, Inc., (NASDAQ: PATI) a healthcare I.T. start-up specializing in the development of disease management programs for the healthcare industry. During his tenure, he hired, trained and managed a national sales force and was instrumental in taking the company public within two years of its formation. Having held various sales and marketing positions, including seven years with Merck and Glaxo Wellcome, he has earned numerous awards for sales and management achievements. Mr. Thomas graduated from Cornell University with a bachelor's degree in Microbiology
 
watchlist Created with Sketch. Add KSX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.